Technical Analysis for 0ACH - MedinCell
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 12.60 | 1.25% | 0.16 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Gilligan's Island Sell Setup | Bearish Swing Setup | 1.25% |
| Alert | Time |
|---|---|
| Fell Below Upper Bollinger Band | about 15 hours ago |
| Possible Inside Day | about 15 hours ago |
| Possible NR7 | about 15 hours ago |
| Possible NR7 | 1 day ago |
| Up 1 ATR | 2 days ago |
Get a Trading Sidekick!
MedinCell Description
MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology. The company's products in development include mdc-IRM, a risperidone extended-release injectable suspension for use in the treatment of schizophrenia in adults; mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-ANG, an antipsychotic product for use in the treatment of schizophrenia; mdc-TTG for Covid-19 and its variants; mdc-GRT for organ transplant; mdc-WWM for contraception; mdc-STM for malaria; and mdc-IRM for neuroscience. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Classification
Keywords: Pain Pharmaceutical Neuroscience Inflammation Malaria Mood Stabilizers Schizophrenia Contraception Lactams
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.6014 |
| 52 Week Low | 5.4 |
| Average Volume | 2,036 |
| 200-Day Moving Average | 7.49 |
| 50-Day Moving Average | 9.66 |
| 20-Day Moving Average | 10.36 |
| 10-Day Moving Average | 11.22 |
| Average True Range | 0.38 |
| RSI (14) | 81.45 |
| ADX | 41.62 |
| +DI | 56.30 |
| -DI | 9.25 |
| Chandelier Exit (Long, 3 ATRs) | 11.47 |
| Chandelier Exit (Short, 3 ATRs) | 10.26 |
| Upper Bollinger Bands | 12.76 |
| Lower Bollinger Band | 7.96 |
| Percent B (%b) | 0.97 |
| BandWidth | 46.31 |
| MACD Line | 0.79 |
| MACD Signal Line | 0.50 |
| MACD Histogram | 0.2899 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 12.69 | ||||
| Resistance 3 (R3) | 12.68 | 12.64 | 12.68 | ||
| Resistance 2 (R2) | 12.64 | 12.62 | 12.65 | 12.67 | |
| Resistance 1 (R1) | 12.62 | 12.60 | 12.63 | 12.63 | 12.67 |
| Pivot Point | 12.58 | 12.58 | 12.59 | 12.59 | 12.58 |
| Support 1 (S1) | 12.56 | 12.56 | 12.57 | 12.57 | 12.53 |
| Support 2 (S2) | 12.52 | 12.54 | 12.52 | 12.53 | |
| Support 3 (S3) | 12.50 | 12.52 | 12.52 | ||
| Support 4 (S4) | 12.51 |
